Drug Profile
Ecteinascidin 729
Alternative Names: ET 729; NSC 638718Latest Information Update: 21 Jan 2017
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 20 Jan 2017 Discontinued - Preclinical for Cancer in Spain (Parenteral)
- 20 Jan 2017 Discontinued - Preclinical for Cancer in USA (Parenteral)
- 08 Oct 1999 ET 729 is now called ecteinascidin 729